PCSK1N and Lewy body dementia: SAAs separate patients with PD and Dementia with Lewy bodies (DLB) from healthy controls with high sensitivity and specificity [14–16] and also allow diagnosis of synucleinopathies in the prodromal stage, such as pure autonomic failure or idiopathic REM sleep behavior disorder [14, 17, 18].